Results 211 to 220 of about 6,471,944 (292)
From neglect to necessity: The case for routine work-up of nontoxigenic <i>Corynebacterium diphtheriae</i> in clinical microbiology. [PDF]
Masemola KR.
europepmc +1 more source
Pectinase‐Based Bioprocesses for Circular Bioeconomy and Sustainable Industrial Development
This picture demonstrates a unified strategy for sustainable pectinase production, focusing on microbial bioproduction, innovative strategies in enzyme engineering (Protein engineering, rational enzyme design, directed evolution and heterologous expression) and various applications in industry, including food, textiles, pulp and paper, agriculture and ...
Nisha Sharma +6 more
wiley +1 more source
Predictors for Publication of Specialty Theses in the Field of Infectious Diseases and Clinical Microbiology. [PDF]
İrkören P +22 more
europepmc +1 more source
SpyCatcher‐mi3 nanoparticles presenting HKU5, NeoCoV, and HKU5‐CoV‐2 RBD‐SD1 induced strong, cross‐reactive IgG responses in immunized mice. The surrogate virus neutralization test demonstrated strong activity in sera from homologous vaccination. ABSTRACT Recent discoveries of merbecoviruses such as HKU5, NeoCoV, and HKU5‐CoV‐2 that use angiotensin ...
Peter J. Halfmann +11 more
wiley +1 more source
Barriers and perceptions of WHONET/BacLink adoption in Nepal: A qualitative study of clinical microbiology laboratories. [PDF]
Maharjan S +17 more
europepmc +1 more source
Lifecycle perspective on cell and gene therapy manufacturing challenges and enabling GMP solutions. ABSTRACT Cell and gene therapies (CGTs) are revolutionizing modern medicine; however, making these advanced medicines scalable and readily available to commercial manufacturers worldwide is a major challenge. The number of approved CGT products continues
Rajath Samaga +2 more
wiley +1 more source
Induction and Enhancement of Bacteriocin Production (Review)
ABSTRACT Conventionally, bacteriocins are produced by microorganisms on complex substrates, released as semi‐purified preparations or crude fermentates. These bacteriocin‐containing products often exhibit unsatisfactory purity, low active‐substance content, and high production costs, limiting their commercialization and use. This review aims to analyze
Oksana Knysh, Artur Martynov
wiley +1 more source
Survey of clinical microbiology and infectious disease testing capabilities among institutions in Africa. [PDF]
Jacobs JW +4 more
europepmc +1 more source

